The global lateral flow assay (LFA) market is projected to grow from USD 10.01 billion in 2024 to USD 15.42 billion by 2030, driven by increasing demand for point-of-care testing and the rising ...

Not long ago, referring to a lateral flow test would have resulted in blank stares, even though they’re common diagnostic devices used in over-the-counter pregnancy tests, for example. But the ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.